https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-72007-06-01 00:00:002007-06-01 00:00:00Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-30 / Physiol Res 2008;57(3):459-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-30 / Physiol Res 2008;57(3):459-652007-05-30 00:00:002007-05-30 00:00:00Immunological response in the mouse melanoma model after local hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-82007-03-01 00:00:002007-03-01 00:00:00Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-442007-03-01 00:00:002007-03-01 00:00:00Point: Hyperthermia with radiation for chest wall recurrences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-01 / Cir Esp 2007 Feb;81(2):82-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-01 / Cir Esp 2007 Feb;81(2):82-62007-02-01 00:00:002007-02-01 00:00:00[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-202007-01-19 00:00:002019-02-15 08:48:20Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-812007-01-01 00:00:002007-01-01 00:00:00Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-308
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-3082006-12-01 00:00:002019-02-15 09:17:43Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-582006-12-01 00:00:002019-02-15 08:48:21Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-952006-11-01 00:00:002006-11-01 00:00:00Hyperthermia and immunity. A brief overview
